$CUR Recent News This tiny biotech company tak
Post# of 44846
Posted On: 01/07/2015 1:16:11 PM
$CUR Recent News
This tiny biotech company takes the real ice bucket challenge 9:14 a.m. Sept. 2, 2014 - Michael Brush
Neuralstem gets FDA okay for depression study 9:28 a.m. Oct. 17, 2012 - MarketWatch.com
Stocks to watch Monday: LDK, OfficeMax 4:27 p.m. Sept. 14, 2012 - William Spain
Friday’s biggest gaining and declining stocks 4:11 p.m. Sept. 14, 2012 - MarketWatch
Hot stocks to watch 6:14 a.m. Sept. 14, 2012 - MarketWatch.com
Stocks to watch Friday: Werner, Libbey, Delphi 6:07 a.m. Sept. 14, 2012 - MarketWatch
Canada hot stocks: Scotiabank, Great Panther 2:29 p.m. Aug. 30, 2011 - MarketWatch
Are stem-cell stocks a good buy? 2:06 p.m. July 13, 2011 - Val Brickates Kennedy
Drug stocks mixed after Fed statement 1:02 p.m. June 22, 2011 - Val Brickates Kennedy
Drug stocks gain while Nanosphere sinks 1:12 p.m. June 21, 2011 - Val Brickates Kennedy
Neuralstem soars on FDA move 2:00 p.m. Feb. 9, 2011 - Val Brickates Kennedy
Neuralstem, Impax in drug-sector spotlight 3:22 p.m. Dec. 16, 2010 - Val Brickates Kennedy
Neuralstem climbs as drug indexes hug flat line 10:02 a.m. Dec. 16, 2010 - Val Brickates Kennedy
Neuralstem soars on FDA nod 9:16 a.m. Dec. 16, 2010 - Val Brickates Kennedy
Before the Close Report from the MarketWatch Radio Network 1:31 p.m. March 9, 2009 - Andrew O'Day
Geron's study OK signals progress for company, stem cell peers 1:13 p.m. Jan. 23, 2009 - MarketWatch.com
2007 could emerge as a pivotal year for stem-cell investing 5:43 p.m. Dec. 12, 2007 - Scott Austin
Palatin plunges on drug setback; Atherogenics continues rally 12:42 p.m. Aug. 30, 2007 - Val Brickates Kennedy
Neuralstem teams up with U Mich. for ALS research 8:26 a.m. Aug. 30, 2007 - Val Brickates Kennedy
Stem cell industry trying to see silver lining in funding fight 11:36 a.m. April 13, 2007 - Greg Presto
15 Biotech Names For 2015 2:37 p.m. Jan. 5, 2015 - Seeking Alpha
First Week Of August 21st Options Trading For Neuralstem (CUR) 11:32 a.m. Jan. 2, 2015 - TheStreet.com
Neuralstem (CUR) Stock Rises Today as Brainstorm Cell Therapeutics Soars 11:02 a.m. Jan. 2, 2015 - TheStreet.com
One Reason Neuralstem (CUR) Stock is Rising Today 12:42 p.m. Dec. 31, 2014 - TheStreet.com
Brainstorm Cell up on clinical trial results 10:25 a.m. Dec. 31, 2014 - Seeking Alpha
InVivo Therapeutics 4:56 p.m. Nov. 12, 2014 - Seeking Alpha
10-Q: NEURALSTEM, INC. 6:37 a.m. Nov. 7, 2014 - Edgar Online - (EDG = 10Q, 10K)
Cytokinetics ALS drug impacts disease progression in Phase 2b trial 9:57 a.m. Oct. 20, 2014 - Seeking Alpha
Genervon ALS drug shows encouraging results 7:27 a.m. Oct. 20, 2014 - Seeking Alpha
InVivo, Neuralstem Treat Spinal Cord Injury Patients 12:53 p.m. Oct. 16, 2014 - Seeking Alpha
Brainstorm CEO Offers Investors a Frank Outlook for ALS Therapy 7:30 a.m. Oct. 16, 2014 - TheStreet.com
First patient dosed in spinal cord injury stem cell trial 9:32 a.m. Oct. 10, 2014 - Seeking Alpha
Investigator presents NSI-566 follow up data 11:52 a.m. Sept. 22, 2014 - Seeking Alpha
Asterias cleared for stem cell trial in spinal cord injury 6:52 a.m. Aug. 27, 2014 - Seeking Alpha
Why Neuralstem Has Plenty Of Upside In The Short Term 7:29 a.m. Aug. 26, 2014 - Seeking Alpha
StemCells, Inc: Short-Term Noise Creates Another Buying Opportunity 7:14 a.m. Aug. 15, 2014 - Seeking Alpha
10-Q: NEURALSTEM, INC. 5:24 a.m. Aug. 8, 2014 - Edgar Online - (EDG = 10Q, 10K)
Researchers Fret as Social Media Lift Drug-Trial Veil 9:30 p.m. July 29, 2014 - The Wall Street Journal Interactive Edition
Second site begins enrolling patients in BrainStorm ALS trial 10:05 a.m. July 15, 2014 - Seeking Alpha
Behind The Promotion Of Northwest Bio 8:35 a.m. July 7, 2014 - Seeking Alpha
Neuralstem To Present At Biotech Showcase 2015 9:03 a.m. Jan. 6, 2015 - PR Newswire - PRF
Neuralstem Announces Publication Of Long Term Cell Survival From Phase I NSI-566 ALS Study In The Journal "Annals Of Clinical And Translational Neurology" 9:00 a.m. Nov. 10, 2014 - PR Newswire - PRF
Neuralstem Reports Third Quarter Financial Results And Provides Business And Clinical Update 9:00 a.m. Nov. 7, 2014 - PR Newswire - PRF
First Patient Treated In Neuralstem Phase I Spinal Cord Injury Stem Cell Trial Through The UC San Diego Sanford Stem Cell Clinical Center 8:15 a.m. Oct. 9, 2014 - PR Newswire - PRF
Neuralstem ALS Investigator Presents Long-Term Follow Up Phase I Data 8:15 a.m. Sept. 22, 2014 - PR Newswire - PRF
Neuralstem President And CEO To Present At The 2014 Rodman & Renshaw Annual Global Investment Conference 8:15 a.m. Sept. 5, 2014 - PR Newswire - PRF
Neuralstem Reports Second Quarter Financial Results And Provides Business And Clinical Update 7:00 a.m. Aug. 8, 2014 - PR Newswire - PRF
Final Patient Treated In Neuralstem Phase II ALS Stem Cell Trial 8:15 a.m. Aug. 4, 2014 - PR Newswire - PRF
Morning Briefing on Biotech Stocks -- Research on Dynavax Technologies, Synergy Pharma, Infinity Pharma, and Neuralstem 6:00 a.m. July 2, 2014 - PR Newswire - PRF
Neuralstem's NSI-189 Novel Neurogenic Compound Shows Significant Effect In Major Depressive Disorder 8:15 a.m. June 25, 2014 - PR Newswire - PRF
Neuralstem NSI-189 Select Data To Be Presented At Neuropsychopharmacology Congress 8:15 a.m. June 19, 2014 - PR Newswire - PRF
Neuralstem Final Phase I Depression Data Presented At The American Society Of Clinical Psychopharmacology Annual Meeting 8:15 a.m. June 18, 2014 - PR Newswire - PRF
Neuralstem, Inc. - "The FDA is Not the Enemy" 8:26 a.m. June 9, 2014 - ACCESSWIRE
Morning Briefing on Top Gainers -- Research on GTx Inc., Iridium Communications, Neuralstem, and Idera Pharma 5:50 a.m. May 29, 2014 - PR Newswire - PRF
Neuralstem, Inc. - "Most men would rather deny a hard truth than face it" 10:36 a.m. May 28, 2014 - ACCESSWIRE
Neuralstem Depression Trial Data to Be Presented at The American Society of Clinical Psychopharmacology Annual Meeting 8:28 a.m. May 23, 2014 - PR Newswire - PRF
Neuralstem Reports First Quarter Financial Results And Provides Business And Clinical Update 8:15 a.m. May 12, 2014 - PR Newswire - PRF
Technical Data on Top Gainers -- Research on Assured Guaranty, Ampio Pharma, Neuralstem, and Kennedy-Wilson Holdings 12:34 p.m. May 9, 2014 - PR Newswire - PRF
Neuralstem Appoints Sandford Drexel Smith, Former Genzyme Executive Vice President, To Board Of Directors 8:15 a.m. May 8, 2014 - PR Newswire - PRF
Neuralstem Spinal Cord Injury Stem Cell Trial Approved To Commence At University Of California, San Diego 8:15 a.m. April 16, 2014 - PR Newswire - PRF
This tiny biotech company takes the real ice bucket challenge 9:14 a.m. Sept. 2, 2014 - Michael Brush
Neuralstem gets FDA okay for depression study 9:28 a.m. Oct. 17, 2012 - MarketWatch.com
Stocks to watch Monday: LDK, OfficeMax 4:27 p.m. Sept. 14, 2012 - William Spain
Friday’s biggest gaining and declining stocks 4:11 p.m. Sept. 14, 2012 - MarketWatch
Hot stocks to watch 6:14 a.m. Sept. 14, 2012 - MarketWatch.com
Stocks to watch Friday: Werner, Libbey, Delphi 6:07 a.m. Sept. 14, 2012 - MarketWatch
Canada hot stocks: Scotiabank, Great Panther 2:29 p.m. Aug. 30, 2011 - MarketWatch
Are stem-cell stocks a good buy? 2:06 p.m. July 13, 2011 - Val Brickates Kennedy
Drug stocks mixed after Fed statement 1:02 p.m. June 22, 2011 - Val Brickates Kennedy
Drug stocks gain while Nanosphere sinks 1:12 p.m. June 21, 2011 - Val Brickates Kennedy
Neuralstem soars on FDA move 2:00 p.m. Feb. 9, 2011 - Val Brickates Kennedy
Neuralstem, Impax in drug-sector spotlight 3:22 p.m. Dec. 16, 2010 - Val Brickates Kennedy
Neuralstem climbs as drug indexes hug flat line 10:02 a.m. Dec. 16, 2010 - Val Brickates Kennedy
Neuralstem soars on FDA nod 9:16 a.m. Dec. 16, 2010 - Val Brickates Kennedy
Before the Close Report from the MarketWatch Radio Network 1:31 p.m. March 9, 2009 - Andrew O'Day
Geron's study OK signals progress for company, stem cell peers 1:13 p.m. Jan. 23, 2009 - MarketWatch.com
2007 could emerge as a pivotal year for stem-cell investing 5:43 p.m. Dec. 12, 2007 - Scott Austin
Palatin plunges on drug setback; Atherogenics continues rally 12:42 p.m. Aug. 30, 2007 - Val Brickates Kennedy
Neuralstem teams up with U Mich. for ALS research 8:26 a.m. Aug. 30, 2007 - Val Brickates Kennedy
Stem cell industry trying to see silver lining in funding fight 11:36 a.m. April 13, 2007 - Greg Presto
15 Biotech Names For 2015 2:37 p.m. Jan. 5, 2015 - Seeking Alpha
First Week Of August 21st Options Trading For Neuralstem (CUR) 11:32 a.m. Jan. 2, 2015 - TheStreet.com
Neuralstem (CUR) Stock Rises Today as Brainstorm Cell Therapeutics Soars 11:02 a.m. Jan. 2, 2015 - TheStreet.com
One Reason Neuralstem (CUR) Stock is Rising Today 12:42 p.m. Dec. 31, 2014 - TheStreet.com
Brainstorm Cell up on clinical trial results 10:25 a.m. Dec. 31, 2014 - Seeking Alpha
InVivo Therapeutics 4:56 p.m. Nov. 12, 2014 - Seeking Alpha
10-Q: NEURALSTEM, INC. 6:37 a.m. Nov. 7, 2014 - Edgar Online - (EDG = 10Q, 10K)
Cytokinetics ALS drug impacts disease progression in Phase 2b trial 9:57 a.m. Oct. 20, 2014 - Seeking Alpha
Genervon ALS drug shows encouraging results 7:27 a.m. Oct. 20, 2014 - Seeking Alpha
InVivo, Neuralstem Treat Spinal Cord Injury Patients 12:53 p.m. Oct. 16, 2014 - Seeking Alpha
Brainstorm CEO Offers Investors a Frank Outlook for ALS Therapy 7:30 a.m. Oct. 16, 2014 - TheStreet.com
First patient dosed in spinal cord injury stem cell trial 9:32 a.m. Oct. 10, 2014 - Seeking Alpha
Investigator presents NSI-566 follow up data 11:52 a.m. Sept. 22, 2014 - Seeking Alpha
Asterias cleared for stem cell trial in spinal cord injury 6:52 a.m. Aug. 27, 2014 - Seeking Alpha
Why Neuralstem Has Plenty Of Upside In The Short Term 7:29 a.m. Aug. 26, 2014 - Seeking Alpha
StemCells, Inc: Short-Term Noise Creates Another Buying Opportunity 7:14 a.m. Aug. 15, 2014 - Seeking Alpha
10-Q: NEURALSTEM, INC. 5:24 a.m. Aug. 8, 2014 - Edgar Online - (EDG = 10Q, 10K)
Researchers Fret as Social Media Lift Drug-Trial Veil 9:30 p.m. July 29, 2014 - The Wall Street Journal Interactive Edition
Second site begins enrolling patients in BrainStorm ALS trial 10:05 a.m. July 15, 2014 - Seeking Alpha
Behind The Promotion Of Northwest Bio 8:35 a.m. July 7, 2014 - Seeking Alpha
Neuralstem To Present At Biotech Showcase 2015 9:03 a.m. Jan. 6, 2015 - PR Newswire - PRF
Neuralstem Announces Publication Of Long Term Cell Survival From Phase I NSI-566 ALS Study In The Journal "Annals Of Clinical And Translational Neurology" 9:00 a.m. Nov. 10, 2014 - PR Newswire - PRF
Neuralstem Reports Third Quarter Financial Results And Provides Business And Clinical Update 9:00 a.m. Nov. 7, 2014 - PR Newswire - PRF
First Patient Treated In Neuralstem Phase I Spinal Cord Injury Stem Cell Trial Through The UC San Diego Sanford Stem Cell Clinical Center 8:15 a.m. Oct. 9, 2014 - PR Newswire - PRF
Neuralstem ALS Investigator Presents Long-Term Follow Up Phase I Data 8:15 a.m. Sept. 22, 2014 - PR Newswire - PRF
Neuralstem President And CEO To Present At The 2014 Rodman & Renshaw Annual Global Investment Conference 8:15 a.m. Sept. 5, 2014 - PR Newswire - PRF
Neuralstem Reports Second Quarter Financial Results And Provides Business And Clinical Update 7:00 a.m. Aug. 8, 2014 - PR Newswire - PRF
Final Patient Treated In Neuralstem Phase II ALS Stem Cell Trial 8:15 a.m. Aug. 4, 2014 - PR Newswire - PRF
Morning Briefing on Biotech Stocks -- Research on Dynavax Technologies, Synergy Pharma, Infinity Pharma, and Neuralstem 6:00 a.m. July 2, 2014 - PR Newswire - PRF
Neuralstem's NSI-189 Novel Neurogenic Compound Shows Significant Effect In Major Depressive Disorder 8:15 a.m. June 25, 2014 - PR Newswire - PRF
Neuralstem NSI-189 Select Data To Be Presented At Neuropsychopharmacology Congress 8:15 a.m. June 19, 2014 - PR Newswire - PRF
Neuralstem Final Phase I Depression Data Presented At The American Society Of Clinical Psychopharmacology Annual Meeting 8:15 a.m. June 18, 2014 - PR Newswire - PRF
Neuralstem, Inc. - "The FDA is Not the Enemy" 8:26 a.m. June 9, 2014 - ACCESSWIRE
Morning Briefing on Top Gainers -- Research on GTx Inc., Iridium Communications, Neuralstem, and Idera Pharma 5:50 a.m. May 29, 2014 - PR Newswire - PRF
Neuralstem, Inc. - "Most men would rather deny a hard truth than face it" 10:36 a.m. May 28, 2014 - ACCESSWIRE
Neuralstem Depression Trial Data to Be Presented at The American Society of Clinical Psychopharmacology Annual Meeting 8:28 a.m. May 23, 2014 - PR Newswire - PRF
Neuralstem Reports First Quarter Financial Results And Provides Business And Clinical Update 8:15 a.m. May 12, 2014 - PR Newswire - PRF
Technical Data on Top Gainers -- Research on Assured Guaranty, Ampio Pharma, Neuralstem, and Kennedy-Wilson Holdings 12:34 p.m. May 9, 2014 - PR Newswire - PRF
Neuralstem Appoints Sandford Drexel Smith, Former Genzyme Executive Vice President, To Board Of Directors 8:15 a.m. May 8, 2014 - PR Newswire - PRF
Neuralstem Spinal Cord Injury Stem Cell Trial Approved To Commence At University Of California, San Diego 8:15 a.m. April 16, 2014 - PR Newswire - PRF
(0)
(0)Scroll down for more posts ▼